SALT LAKE CITY, Nov. 06, 2017 (GLOBE NEWSWIRE) — Amedica CorporationĀ (Nasdaq:AMDA), an innovative biomaterial company that develops and manufactures silicon nitride as a platform for biomedical applications, announced that the company made a 510(k) submission to the U.S Food and Drug Administration for itsĀ  Valeo C+CSC with Lumen spinal implant. […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone